Covid-19 Impact on Global Multidrug Resistant Bacteria Treatment Market Size, Status and Forecast 2020-2026

June 2020 | 128 pages | ID: C2E8A08A4725EN
QYResearch

Abstracts

Multidrug Resistant Bacteria Treatment market is segmented by Route of Administration, and by Application. Players, stakeholders, and other participants in the global Multidrug Resistant Bacteria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Route of Administration and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Multidrug Resistant Bacteria Treatment market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Multidrug Resistant Bacteria Treatment industry.
The key players covered in this study

• Nabriva Therapeutics
• BioVersys
• Johnson & Johnson
• Destiny Pharma
• Armata Pharmaceuticals
• Westway Health
• Nemesis Bioscience
• Tetraphase Pharmaceuticals
• Allergan
• Merck
• Pfizer
• CARB-X
• Melinta Therapeutics
• Novartis
• Vertex Pharmaceuticals Incorporated
• GlaxoSmithKline
• AbbVie
• Roche

Market segment by Route of Administration, the product can be split into

• Oral
• Parenteral
• Others

Market segment by Application, split into

• Hospital
• Special Clinic
• Recovery Center

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Multidrug Resistant Bacteria Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Multidrug Resistant Bacteria Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by route of administration, market and key regions.

In this study, the years considered to estimate the market size of Multidrug Resistant Bacteria Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, route of administration and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multidrug Resistant Bacteria Treatment Revenue
1.4 Covid-19 Implications on Market by Route of Administration
  1.4.1 Global Multidrug Resistant Bacteria Treatment Market Size Growth Rate by Route of Administration: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Parenteral
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Multidrug Resistant Bacteria Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Special Clinic
  1.5.4 Recovery Center
1.6 Coronavirus Disease 2019 (Covid-19): Multidrug Resistant Bacteria Treatment Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Multidrug Resistant Bacteria Treatment Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Multidrug Resistant Bacteria Treatment Growth Trends by Regions
  2.2.1 Multidrug Resistant Bacteria Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Multidrug Resistant Bacteria Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Multidrug Resistant Bacteria Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Multidrug Resistant Bacteria Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Multidrug Resistant Bacteria Treatment Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Multidrug Resistant Bacteria Treatment Players by Market Size
  3.1.1 Global Top Multidrug Resistant Bacteria Treatment Players by Revenue (2015-2020)
  3.1.2 Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Multidrug Resistant Bacteria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multidrug Resistant Bacteria Treatment Market Concentration Ratio
  3.2.1 Global Multidrug Resistant Bacteria Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Multidrug Resistant Bacteria Treatment Revenue in 2019
3.3 Multidrug Resistant Bacteria Treatment Key Players Head office and Area Served
3.4 Key Players Multidrug Resistant Bacteria Treatment Product Solution and Service
3.5 Date of Enter into Multidrug Resistant Bacteria Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY ROUTE OF ADMINISTRATION (2015-2026)

4.1 Global Multidrug Resistant Bacteria Treatment Historic Market Size by Route of Administration (2015-2020)
4.2 Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Route of Administration (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)
5.2 Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
6.2 Multidrug Resistant Bacteria Treatment Key Players in North America (2019-2020)
6.3 North America Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020)
6.4 North America Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
7.2 Multidrug Resistant Bacteria Treatment Key Players in Europe (2019-2020)
7.3 Europe Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020)
7.4 Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
8.2 Multidrug Resistant Bacteria Treatment Key Players in China (2019-2020)
8.3 China Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020)
8.4 China Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
9.2 Multidrug Resistant Bacteria Treatment Key Players in Japan (2019-2020)
9.3 Japan Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020)
9.4 Japan Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
10.2 Multidrug Resistant Bacteria Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multidrug Resistant Bacteria Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
11.2 Multidrug Resistant Bacteria Treatment Key Players in India (2019-2020)
11.3 India Multidrug Resistant Bacteria Treatment Market Size by Type (2015-2020)
11.4 India Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Multidrug Resistant Bacteria Treatment Market Size (2015-2020)
12.2 Multidrug Resistant Bacteria Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Multidrug Resistant Bacteria Treatment Market Size by Type (2015-2020)
12.4 Central & South America Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Nabriva Therapeutics
  13.1.1 Nabriva Therapeutics Company Details
  13.1.2 Nabriva Therapeutics Business Overview and Its Total Revenue
  13.1.3 Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Introduction
  13.1.4 Nabriva Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020))
  13.1.5 Nabriva Therapeutics Recent Development and Reaction to COVID-19
13.2 BioVersys
  13.2.1 BioVersys Company Details
  13.2.2 BioVersys Business Overview and Its Total Revenue
  13.2.3 BioVersys Multidrug Resistant Bacteria Treatment Introduction
  13.2.4 BioVersys Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.2.5 BioVersys Recent Development and Reaction to COVID-19
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Details
  13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Multidrug Resistant Bacteria Treatment Introduction
  13.3.4 Johnson & Johnson Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.3.5 Johnson & Johnson Recent Development and Reaction to COVID-19
13.4 Destiny Pharma
  13.4.1 Destiny Pharma Company Details
  13.4.2 Destiny Pharma Business Overview and Its Total Revenue
  13.4.3 Destiny Pharma Multidrug Resistant Bacteria Treatment Introduction
  13.4.4 Destiny Pharma Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.4.5 Destiny Pharma Recent Development and Reaction to COVID-19
13.5 Armata Pharmaceuticals
  13.5.1 Armata Pharmaceuticals Company Details
  13.5.2 Armata Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Introduction
  13.5.4 Armata Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.5.5 Armata Pharmaceuticals Recent Development and Reaction to COVID-19
13.6 Westway Health
  13.6.1 Westway Health Company Details
  13.6.2 Westway Health Business Overview and Its Total Revenue
  13.6.3 Westway Health Multidrug Resistant Bacteria Treatment Introduction
  13.6.4 Westway Health Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.6.5 Westway Health Recent Development and Reaction to COVID-19
13.7 Nemesis Bioscience
  13.7.1 Nemesis Bioscience Company Details
  13.7.2 Nemesis Bioscience Business Overview and Its Total Revenue
  13.7.3 Nemesis Bioscience Multidrug Resistant Bacteria Treatment Introduction
  13.7.4 Nemesis Bioscience Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.7.5 Nemesis Bioscience Recent Development and Reaction to COVID-19
13.8 Tetraphase Pharmaceuticals
  13.8.1 Tetraphase Pharmaceuticals Company Details
  13.8.2 Tetraphase Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Introduction
  13.8.4 Tetraphase Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.8.5 Tetraphase Pharmaceuticals Recent Development and Reaction to COVID-19
13.9 Allergan
  13.9.1 Allergan Company Details
  13.9.2 Allergan Business Overview and Its Total Revenue
  13.9.3 Allergan Multidrug Resistant Bacteria Treatment Introduction
  13.9.4 Allergan Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.9.5 Allergan Recent Development and Reaction to COVID-19
13.10 Merck
  13.10.1 Merck Company Details
  13.10.2 Merck Business Overview and Its Total Revenue
  13.10.3 Merck Multidrug Resistant Bacteria Treatment Introduction
  13.10.4 Merck Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  13.10.5 Merck Recent Development and Reaction to COVID-19
13.11 Pfizer
  10.11.1 Pfizer Company Details
  10.11.2 Pfizer Business Overview and Its Total Revenue
  10.11.3 Pfizer Multidrug Resistant Bacteria Treatment Introduction
  10.11.4 Pfizer Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.11.5 Pfizer Recent Development and Reaction to COVID-19
13.12 CARB-X
  10.12.1 CARB-X Company Details
  10.12.2 CARB-X Business Overview and Its Total Revenue
  10.12.3 CARB-X Multidrug Resistant Bacteria Treatment Introduction
  10.12.4 CARB-X Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.12.5 CARB-X Recent Development and Reaction to COVID-19
13.13 Melinta Therapeutics
  10.13.1 Melinta Therapeutics Company Details
  10.13.2 Melinta Therapeutics Business Overview and Its Total Revenue
  10.13.3 Melinta Therapeutics Multidrug Resistant Bacteria Treatment Introduction
  10.13.4 Melinta Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.13.5 Melinta Therapeutics Recent Development and Reaction to COVID-19
13.14 Novartis
  10.14.1 Novartis Company Details
  10.14.2 Novartis Business Overview and Its Total Revenue
  10.14.3 Novartis Multidrug Resistant Bacteria Treatment Introduction
  10.14.4 Novartis Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.14.5 Novartis Recent Development and Reaction to COVID-19
13.15 Vertex Pharmaceuticals Incorporated
  10.15.1 Vertex Pharmaceuticals Incorporated Company Details
  10.15.2 Vertex Pharmaceuticals Incorporated Business Overview and Its Total Revenue
  10.15.3 Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Introduction
  10.15.4 Vertex Pharmaceuticals Incorporated Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.15.5 Vertex Pharmaceuticals Incorporated Recent Development and Reaction to COVID-19
13.16 GlaxoSmithKline
  10.16.1 GlaxoSmithKline Company Details
  10.16.2 GlaxoSmithKline Business Overview and Its Total Revenue
  10.16.3 GlaxoSmithKline Multidrug Resistant Bacteria Treatment Introduction
  10.16.4 GlaxoSmithKline Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.16.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.17 AbbVie
  10.17.1 AbbVie Company Details
  10.17.2 AbbVie Business Overview and Its Total Revenue
  10.17.3 AbbVie Multidrug Resistant Bacteria Treatment Introduction
  10.17.4 AbbVie Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.17.5 AbbVie Recent Development and Reaction to COVID-19
13.18 Roche
  10.18.1 Roche Company Details
  10.18.2 Roche Business Overview and Its Total Revenue
  10.18.3 Roche Multidrug Resistant Bacteria Treatment Introduction
  10.18.4 Roche Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020)
  10.18.5 Roche Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Multidrug Resistant Bacteria Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Multidrug Resistant Bacteria Treatment Revenue
Table 3. Ranking of Global Top Multidrug Resistant Bacteria Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multidrug Resistant Bacteria Treatment Market Size Growth Rate by Route of Administration (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Multidrug Resistant Bacteria Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Multidrug Resistant Bacteria Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Multidrug Resistant Bacteria Treatment Players to Combat Covid-19 Impact
Table 13. Global Multidrug Resistant Bacteria Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Multidrug Resistant Bacteria Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Multidrug Resistant Bacteria Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2015-2020)
Table 17. Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Multidrug Resistant Bacteria Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Multidrug Resistant Bacteria Treatment Players
Table 24. Global Multidrug Resistant Bacteria Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Multidrug Resistant Bacteria Treatment Market Share by Players (2015-2020)
Table 26. Global Top Multidrug Resistant Bacteria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multidrug Resistant Bacteria Treatment as of 2019)
Table 27. Global Multidrug Resistant Bacteria Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Multidrug Resistant Bacteria Treatment Product Solution and Service
Table 30. Date of Enter into Multidrug Resistant Bacteria Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 33. Global Multidrug Resistant Bacteria Treatment Market Size Share by Route of Administration (2015-2020)
Table 34. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Route of Administration (2021-2026)
Table 35. Global Multidrug Resistant Bacteria Treatment Market Size Share by Application (2015-2020)
Table 36. Global Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Multidrug Resistant Bacteria Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 40. North America Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 41. North America Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 42. North America Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 46. Europe Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 47. Europe Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 48. Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 52. China Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 53. China Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 54. China Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 58. Japan Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 59. Japan Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 60. Japan Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 64. Southeast Asia Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 65. Southeast Asia Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 66. Southeast Asia Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 70. India Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 71. India Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 72. India Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Multidrug Resistant Bacteria Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Multidrug Resistant Bacteria Treatment Market Share (2019-2020)
Table 76. Central & South America Multidrug Resistant Bacteria Treatment Market Size by Route of Administration (2015-2020) (Million US$)
Table 77. Central & South America Multidrug Resistant Bacteria Treatment Market Share by Route of Administration (2015-2020)
Table 78. Central & South America Multidrug Resistant Bacteria Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Multidrug Resistant Bacteria Treatment Market Share by Application (2015-2020)
Table 80. Nabriva Therapeutics Company Details
Table 81. Nabriva Therapeutics Business Overview
Table 82. Nabriva Therapeutics Product
Table 83. Nabriva Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 84. Nabriva Therapeutics Recent Development
Table 85. BioVersys Company Details
Table 86. BioVersys Business Overview
Table 87. BioVersys Product
Table 88. BioVersys Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 89. BioVersys Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 94. Johnson & Johnson Recent Development
Table 95. Destiny Pharma Company Details
Table 96. Destiny Pharma Business Overview
Table 97. Destiny Pharma Product
Table 98. Destiny Pharma Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 99. Destiny Pharma Recent Development
Table 100. Armata Pharmaceuticals Company Details
Table 101. Armata Pharmaceuticals Business Overview
Table 102. Armata Pharmaceuticals Product
Table 103. Armata Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 104. Armata Pharmaceuticals Recent Development
Table 105. Westway Health Company Details
Table 106. Westway Health Business Overview
Table 107. Westway Health Product
Table 108. Westway Health Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 109. Westway Health Recent Development
Table 110. Nemesis Bioscience Company Details
Table 111. Nemesis Bioscience Business Overview
Table 112. Nemesis Bioscience Product
Table 113. Nemesis Bioscience Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 114. Nemesis Bioscience Recent Development
Table 115. Tetraphase Pharmaceuticals Business Overview
Table 116. Tetraphase Pharmaceuticals Product
Table 117. Tetraphase Pharmaceuticals Company Details
Table 118. Tetraphase Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 119. Tetraphase Pharmaceuticals Recent Development
Table 120. Allergan Company Details
Table 121. Allergan Business Overview
Table 122. Allergan Product
Table 123. Allergan Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 124. Allergan Recent Development
Table 125. Merck Company Details
Table 126. Merck Business Overview
Table 127. Merck Product
Table 128. Merck Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 129. Merck Recent Development
Table 130. Pfizer Company Details
Table 131. Pfizer Business Overview
Table 132. Pfizer Product
Table 133. Pfizer Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 134. Pfizer Recent Development
Table 135. CARB-X Company Details
Table 136. CARB-X Business Overview
Table 137. CARB-X Product
Table 138. CARB-X Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 139. CARB-X Recent Development
Table 140. Melinta Therapeutics Company Details
Table 141. Melinta Therapeutics Business Overview
Table 142. Melinta Therapeutics Product
Table 143. Melinta Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 144. Melinta Therapeutics Recent Development
Table 145. Novartis Company Details
Table 146. Novartis Business Overview
Table 147. Novartis Product
Table 148. Novartis Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 149. Novartis Recent Development
Table 150. Vertex Pharmaceuticals Incorporated Company Details
Table 151. Vertex Pharmaceuticals Incorporated Business Overview
Table 152. Vertex Pharmaceuticals Incorporated Product
Table 153. Vertex Pharmaceuticals Incorporated Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 154. Vertex Pharmaceuticals Incorporated Recent Development
Table 155. GlaxoSmithKline Company Details
Table 156. GlaxoSmithKline Business Overview
Table 157. GlaxoSmithKline Product
Table 158. GlaxoSmithKline Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 159. GlaxoSmithKline Recent Development
Table 160. AbbVie Company Details
Table 161. AbbVie Business Overview
Table 162. AbbVie Product
Table 163. AbbVie Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 164. AbbVie Recent Development
Table 165. Roche Company Details
Table 166. Roche Business Overview
Table 167. Roche Product
Table 168. Roche Revenue in Multidrug Resistant Bacteria Treatment Business (2015-2020) (Million US$)
Table 169. Roche Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Multidrug Resistant Bacteria Treatment Market Share by Route of Administration: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Others Features
Figure 5. Global Multidrug Resistant Bacteria Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Special Clinic Case Studies
Figure 8. Recovery Center Case Studies
Figure 9. Multidrug Resistant Bacteria Treatment Report Years Considered
Figure 10. Global Multidrug Resistant Bacteria Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Multidrug Resistant Bacteria Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Multidrug Resistant Bacteria Treatment Market Share by Players in 2019
Figure 15. Global Top Multidrug Resistant Bacteria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multidrug Resistant Bacteria Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Multidrug Resistant Bacteria Treatment Revenue in 2019
Figure 17. North America Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Nabriva Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Nabriva Therapeutics Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 26. BioVersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. BioVersys Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 28. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Johnson & Johnson Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 30. Destiny Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Destiny Pharma Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 32. Armata Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Armata Pharmaceuticals Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 34. Westway Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Westway Health Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 36. Nemesis Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Nemesis Bioscience Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 38. Tetraphase Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Tetraphase Pharmaceuticals Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 40. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Allergan Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 42. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 44. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Pfizer Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 46. CARB-X Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. CARB-X Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 48. Melinta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Melinta Therapeutics Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 52. Vertex Pharmaceuticals Incorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 54. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. GlaxoSmithKline Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 56. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AbbVie Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 58. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Roche Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed